Sintx technologies sells technology assesment and transfer subsidiary to focus on medical device market

Strategic transaction enhances financial flexibility and supports growth in healthcare innovations salt lake city, ut, feb. 20, 2025 (globe newswire) -- sintx technologies, inc. (nasdaq: sint), a leader in advanced ceramics for medical applications, today announced the sale of its wholly-owned subsidiary, technology assessment and transfer (ta&t), to tethon corporation dba tethon 3d (tethon). this transaction marks a significant step in sintx's ongoing transformation, allowing the company to sharpen its focus on high-growth opportunities in the medical device sector while improving its financial position and operational efficiency.
SINT Ratings Summary
SINT Quant Ranking